Research map: Comparing the Effect of Changes in Alcohol Intake on Liver Fibrosis Risk Scores Among Patients With Two Distinct Types of Steatotic Liver Disease

Back to the article

Papers in this map

  1. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease · 2016 · 4899 citations · Cited by this paper
  2. Comments on “Comparing the Effect of Changes in Alcohol Intake on Liver Fibrosis Risk Scores Among Patients With Two Distinct Types of Steatotic Liver Disease” · Yunfu Feng · 2026 · Cites this paper
  3. Comparative Effectiveness and Safety of Atezolizumab–Bevacizumab and Durvalumab–Tremelimumab as First‐Line Systemic Therapy for Hepatocellular Carcinoma: A Real‐World Study · 2026 · Related
  4. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review · Zobair M. Younossi · 2023 · 3310 citations · Cited by this paper
  5. Antibiotic Resistance Heterogeneity as an Unmeasured Confounder in Tegoprazan–Amoxicillin Dual Therapy Meta‐Analysis · 2026 · Related
  6. A multisociety Delphi consensus statement on new fatty liver disease nomenclature · Mary Eugenia Rinella · 2023 · 3201 citations · Cited by this paper
  7. Prospective Clinical Evaluation of a Novel Repositionable Plastic Stent for Endosonography‐Guided Hepaticogastrostomy With or Without Antegrade Stenting (With Videos) · 2026 · Related
  8. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease · Paul G. Angulo · 2015 · 3025 citations · Cited by this paper
  9. Response to Interpreting Survival Differences Between Early‐Onset and Later‐Onset Colorectal Cancer: Methodological Considerations · 2026 · Related
  10. Non-alcoholic fatty liver disease · Elizabeth Ellen Powell · 2021 · 2844 citations · Cited by this paper
  11. Response to Hassan et al. Regarding the J‐GESS Score · 2026 · Related
  12. Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome · Giulio Marchesini · 2003 · 2695 citations · Cited by this paper
  13. Methodological Considerations in Interpreting IL‐15 Plus Thymosin α1 Therapy for Hepatocellular Carcinoma · 2026 · Related
  14. Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up · Mattias Ekstedt · 2014 · 2304 citations · Cited by this paper
  15. Association Between ADH1B rs1229984 Genetic Polymorphism and Hepatic Steatosis Assessed by CT Attenuation: A Mediation Analysis of Central Obesity in MASLD · 2026 · Related
  16. The utility of radiological imaging in nonalcoholic fatty liver disease · Sherif N. Saadeh · 2002 · 2138 citations · Cited by this paper
  17. Comments on “Does Local Excision Without Salvage Surgery Affect the Prognostic Outcome of Patients with Malignant Colorectal Polyp? A Long‐Term Survival Analysis” · 2026 · Related
  18. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis · Parambir Singh Dulai · 2017 · 1972 citations · Cited by this paper
  19. Efficacy of a Dairy‐Free Diet in Adult Patients With Eosinophilic Esophagitis: A Pilot Prospective Multicenter Study · 2026 · Related
  20. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis · Rubén Hernáez · 2011 · 1602 citations · Cited by this paper
  21. Nonalcoholic Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Liver Fibrosis in the Severely Obese · John B. Dixon · 2001 · 1367 citations · Cited by this paper
  22. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD · Hannes Hagström · 2017 · 1099 citations · Cited by this paper
  23. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis · Rod S. Taylor · 2020 · 1072 citations · Cited by this paper
  24. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease · Stuart McPherson · 2010 · 958 citations · Cited by this paper
  25. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease · Mark R. Thursz · 2018 · 943 citations · Cited by this paper
  26. Noninvasive biomarkers in NAFLD and NASH — current progress and future promise · Vincent Wai‐Sun Wong · 2018 · 632 citations · Cited by this paper
  27. Drinking habits as cofactors of risk for alcohol induced liver damage · Stefano Bellentani · 1997 · 631 citations · Cited by this paper
  28. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach · Michael Huan Le · 2022 · 352 citations · Cited by this paper
  29. Advances in non-invasive assessment of hepatic fibrosis · Rohit Seth Loomba · 2020 · 345 citations · Cited by this paper
  30. Joint Effects of Body Weight and Alcohol on Elevated Serum Alanine Aminotransferase in the United States Population · Constance E. Ruhl · 2005 · 241 citations · Cited by this paper
  31. Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis · Cheng Han Ng · 2022 · 215 citations · Cited by this paper
  32. Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease · David Martí Aguado · 2024 · 202 citations · Cited by this paper
  33. Nonalcoholic Steatohepatitis and the Metabolic Syndrome · Brent A. Neuschwander‐Tetri · 2005 · 197 citations · Cited by this paper
  34. Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population · Stefano Ciardullo · 2021 · 196 citations · Cited by this paper
  35. Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals · Silvia C. Sookoian · 2013 · 165 citations · Cited by this paper
  36. Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study · Yoosoo Chang · 2018 · 163 citations · Cited by this paper
  37. Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention · Naomi Franziska Lange · 2021 · 138 citations · Cited by this paper
  38. Exploring the landscape of steatotic liver disease in the general US population · Stefano Ciardullo · 2023 · 125 citations · Cited by this paper
  39. Sex Differences in Alcohol Consumption and Alcohol-Associated Liver Disease · Camille A. Kezer · 2021 · 124 citations · Cited by this paper

Source: OpenAlex (CC0)